Antifungals – Synergy, indifference and antagonism
A combination of antifungals is often used in cases of difficult-to-treat infections. What is the evidence in the literature about synergy, antagonism and indifference?
| Drug 1 | Drug 2 | Candida | Aspergillus | Cryptococcus neoformans | |
| Amphotericin B | Echinocandin | Indifference (survival – NA) | Synergy, Indifference (Survival ↑) | Synergy (survival – NA) | |
| Amphotericin B | Flucytosine | Synergy, indifference (Survival ↑) | Synergy, indifference, antagonism (Survival ↑) | Synergy, indifference, antagonism (Survival ↑/↓) | |
| Amphotericin B | Azoles | Antagonism (Survival ↔/↓/↑) | Synergy, indifference, antagonism (Survival ↔/↓) | Indifference (Survival ↑/↓) | |
| Echinocandin | Azoles | Synergy (Ahmadi 2020) | Synergy, indifference (Survival ↑) | Indifference (survival – NA) | |
| Azoles | Flucytosine | Synergy, indifference, antagonism (Survival ↑) | Synergy, indifference (Survival ↑/↓) |
L.Ostrosky-Zeichner, Combination antifungal therapy: a critical review of the evidence, Clinical Microbiology and Infection Volume 14, Supplement 4, May 2008, Pages 65-70
Disclaimer: This is for academic use only. Managing an infection is complex and depends on taking multiple factors into account. Please speak to your doctor for clinical advice. This article must never be used for clinical purposes.
